TGA to review HRT warnings

The local drug regulator says it will carry out its own analysis after the US FDA promised to remove warnings it labelled “medical dogma rooted in a distortion of risk” Australia’s pharmaceutical regulator will ‘independently consider the data’ behind planned changes to US hormone replacement therapy (HRT) warnings, after health secretary Robert F Kennedy (RFK)